SCHEMBL26466915

SCHEMBL26466915

COc1cc(Cl)cc(NC(=O)CN2C[C@@H]3C[C@H]2CN3CC(=O)NC2(C(F)(F)F)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 4/20 0.46
CXCR6 O00574 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LTA4H P09960 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
LMNA P02545 1/20 0.37
MCHR1 Q99705 1/20 0.37
EPHX2 P34913 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26466903 0.90 CACNA1H (0.50) CACNA1HALDH1A1MAPTKDM4ELTA4H
SCHEMBL26466009 0.89 CACNA1H (0.49) CACNA1HCXCR6ALDH1A1MAPTKDM4E
SCHEMBL26466909 0.88 CACNA1H (0.44) CACNA1HCXCR6ALDH1A1MAPTLTA4H
SCHEMBL26466415 0.87 CACNA1H (0.53) CACNA1HCXCR6ALDH1A1LTA4HMCHR1
SCHEMBL26466233 0.87 CACNA1H (0.53) CACNA1HCXCR6ALDH1A1LTA4HMCHR1
SCHEMBL26466914 0.83 L3MBTL1 (0.43) CACNA1HCXCR6ALDH1A1MAPTKDM4E
SCHEMBL26466922 0.81 CACNA1H (0.41) CACNA1HCXCR6ALDH1A1MAPTKDM4E
SCHEMBL26466250 0.80 HPGD (0.49) CACNA1HALDH1A1MAPTKDM4ESMN1; SMN2
SCHEMBL26466919 0.80 CACNA1H (0.42) CACNA1HALDH1A1MAPTLTA4HSMN1; SMN2
SCHEMBL26466243 0.80 HPGD (0.49) CACNA1HALDH1A1MAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192669-A1 T-TYPE CALCIUM CHANNEL MODULATORS COMPRISING A PIPERAZINE OR 1,4-DIAZEPANE CORE AND METHODS OF USE THEREOF PRAXIS PRECISION MEDICINES, INC. (US) 2023-10-05 WO disclosed